Search Results - Roberto Di Virgilio
- Showing 1 - 1 results of 1
-
1
Cost-effectiveness analysis of gemtuzumab ozogamicin for the treatment of de novo CD33-positive Acute Myeloid Leukaemia (AML) in Italy by Roberto Cairoli, Gianluca Furneri, Roberto Di Virgilio, Barbara Veggia, Felicetto Ferrara
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book